Concepts (209)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cytochrome P-450 CYP3A | 9 | 2021 | 60 | 2.740 |
Why?
|
| Glucuronosyltransferase | 9 | 2022 | 71 | 2.600 |
Why?
|
| Camptothecin | 5 | 2022 | 79 | 2.470 |
Why?
|
| Antineoplastic Agents, Phytogenic | 5 | 2022 | 111 | 2.450 |
Why?
|
| Liver | 10 | 2021 | 1876 | 1.660 |
Why?
|
| Toll-Like Receptor 4 | 4 | 2022 | 145 | 1.380 |
Why?
|
| Hepatocytes | 6 | 2021 | 245 | 1.160 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 4 | 2018 | 93 | 1.060 |
Why?
|
| Lipopolysaccharides | 6 | 2019 | 319 | 1.020 |
Why?
|
| Inactivation, Metabolic | 4 | 2018 | 32 | 0.990 |
Why?
|
| Paclitaxel | 2 | 2017 | 143 | 0.970 |
Why?
|
| Gene Expression Regulation | 5 | 2019 | 2669 | 0.910 |
Why?
|
| Enzymes | 2 | 2017 | 50 | 0.880 |
Why?
|
| Toll-Like Receptor 2 | 3 | 2022 | 59 | 0.830 |
Why?
|
| Membrane Transport Proteins | 3 | 2013 | 188 | 0.790 |
Why?
|
| Receptors, Steroid | 4 | 2018 | 276 | 0.750 |
Why?
|
| Myeloid Differentiation Factor 88 | 1 | 2022 | 101 | 0.720 |
Why?
|
| Diarrhea | 5 | 2022 | 343 | 0.720 |
Why?
|
| Membrane Proteins | 5 | 2019 | 1621 | 0.680 |
Why?
|
| Receptors, Interleukin-1 | 2 | 2011 | 29 | 0.630 |
Why?
|
| Cytochrome P-450 Enzyme System | 3 | 2015 | 142 | 0.630 |
Why?
|
| Tumor Necrosis Factor-alpha | 4 | 2016 | 701 | 0.620 |
Why?
|
| Chemical and Drug Induced Liver Injury | 1 | 2020 | 125 | 0.610 |
Why?
|
| Multidrug Resistance-Associated Proteins | 2 | 2017 | 27 | 0.610 |
Why?
|
| Inflammation | 4 | 2022 | 1595 | 0.610 |
Why?
|
| Rifampin | 2 | 2018 | 136 | 0.590 |
Why?
|
| Toxicity Tests | 1 | 2018 | 36 | 0.580 |
Why?
|
| Antineoplastic Agents | 2 | 2020 | 1853 | 0.580 |
Why?
|
| Pharmaceutical Preparations | 2 | 2021 | 91 | 0.530 |
Why?
|
| Cytokines | 5 | 2017 | 1397 | 0.530 |
Why?
|
| Membrane Glycoproteins | 2 | 2011 | 432 | 0.530 |
Why?
|
| Gastrointestinal Diseases | 1 | 2020 | 362 | 0.510 |
Why?
|
| Animals | 23 | 2022 | 36518 | 0.510 |
Why?
|
| Teichoic Acids | 3 | 2013 | 13 | 0.500 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2016 | 2137 | 0.490 |
Why?
|
| Glucuronates | 1 | 2015 | 7 | 0.490 |
Why?
|
| Toll-Like Receptor 3 | 1 | 2015 | 22 | 0.490 |
Why?
|
| Topoisomerase I Inhibitors | 1 | 2015 | 18 | 0.490 |
Why?
|
| Adaptor Proteins, Vesicular Transport | 1 | 2015 | 51 | 0.480 |
Why?
|
| Mice, Inbred C57BL | 9 | 2021 | 4881 | 0.480 |
Why?
|
| Mice | 15 | 2022 | 19043 | 0.460 |
Why?
|
| Biological Products | 1 | 2017 | 138 | 0.460 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 3 | 2013 | 396 | 0.440 |
Why?
|
| Toll-Like Receptors | 1 | 2013 | 85 | 0.410 |
Why?
|
| Obesity | 3 | 2015 | 2448 | 0.400 |
Why?
|
| Carboxylesterase | 3 | 2018 | 15 | 0.400 |
Why?
|
| Pharmacokinetics | 1 | 2012 | 16 | 0.400 |
Why?
|
| Biological Transport | 1 | 2013 | 371 | 0.400 |
Why?
|
| Transcriptome | 1 | 2019 | 1135 | 0.380 |
Why?
|
| Gene Expression Profiling | 1 | 2019 | 1922 | 0.370 |
Why?
|
| Gene Expression Regulation, Enzymologic | 2 | 2015 | 260 | 0.370 |
Why?
|
| Gene Expression | 2 | 2013 | 1622 | 0.360 |
Why?
|
| Diet | 1 | 2018 | 1194 | 0.350 |
Why?
|
| Cells, Cultured | 6 | 2021 | 3180 | 0.330 |
Why?
|
| Chlorpromazine | 1 | 2010 | 13 | 0.330 |
Why?
|
| Dietary Fats | 1 | 2011 | 300 | 0.310 |
Why?
|
| Acetaminophen | 1 | 2010 | 102 | 0.300 |
Why?
|
| Signal Transduction | 7 | 2020 | 4936 | 0.280 |
Why?
|
| Drug Interactions | 3 | 2017 | 260 | 0.280 |
Why?
|
| Down-Regulation | 3 | 2017 | 718 | 0.270 |
Why?
|
| Glucuronidase | 2 | 2018 | 32 | 0.270 |
Why?
|
| Enzyme Induction | 2 | 2018 | 103 | 0.260 |
Why?
|
| Hep G2 Cells | 2 | 2018 | 98 | 0.260 |
Why?
|
| Transcription Factor TFIIA | 1 | 2004 | 2 | 0.220 |
Why?
|
| RNA, Ribosomal, 5S | 1 | 2004 | 8 | 0.220 |
Why?
|
| Male | 14 | 2021 | 66171 | 0.220 |
Why?
|
| Xenopus | 1 | 2004 | 115 | 0.220 |
Why?
|
| Fatty Liver | 2 | 2018 | 215 | 0.210 |
Why?
|
| Uridine Diphosphate | 1 | 2022 | 6 | 0.200 |
Why?
|
| Biliary Tract | 2 | 2020 | 15 | 0.190 |
Why?
|
| Area Under Curve | 2 | 2020 | 333 | 0.190 |
Why?
|
| Mice, Mutant Strains | 2 | 2017 | 400 | 0.190 |
Why?
|
| Interleukin-2 | 2 | 2001 | 245 | 0.180 |
Why?
|
| Liver Neoplasms | 1 | 2012 | 1416 | 0.180 |
Why?
|
| Cyclins | 1 | 2001 | 105 | 0.180 |
Why?
|
| Half-Life | 1 | 2019 | 162 | 0.160 |
Why?
|
| Interleukin-6 | 1 | 2001 | 450 | 0.160 |
Why?
|
| Drugs, Chinese Herbal | 1 | 2019 | 24 | 0.150 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2019 | 361 | 0.150 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2001 | 507 | 0.150 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2022 | 628 | 0.150 |
Why?
|
| Quinolines | 1 | 2019 | 114 | 0.140 |
Why?
|
| ROC Curve | 1 | 2019 | 611 | 0.140 |
Why?
|
| Enzyme Activation | 1 | 2019 | 651 | 0.140 |
Why?
|
| Retinoid X Receptor alpha | 2 | 2008 | 20 | 0.140 |
Why?
|
| Busulfan | 1 | 2017 | 45 | 0.140 |
Why?
|
| Administration, Oral | 1 | 2019 | 725 | 0.140 |
Why?
|
| RNA, Messenger | 2 | 2015 | 2915 | 0.140 |
Why?
|
| Models, Theoretical | 1 | 2019 | 398 | 0.140 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2019 | 294 | 0.130 |
Why?
|
| Mice, Inbred C3H | 1 | 2017 | 123 | 0.130 |
Why?
|
| Antineoplastic Agents, Alkylating | 1 | 2017 | 104 | 0.130 |
Why?
|
| In Vitro Techniques | 3 | 2008 | 986 | 0.130 |
Why?
|
| Drug Monitoring | 1 | 2017 | 185 | 0.120 |
Why?
|
| Intestines | 1 | 2020 | 614 | 0.120 |
Why?
|
| Poly I-C | 1 | 2015 | 25 | 0.120 |
Why?
|
| Luciferases | 1 | 2016 | 139 | 0.120 |
Why?
|
| RNA, Small Interfering | 1 | 2018 | 720 | 0.120 |
Why?
|
| Metabolome | 1 | 2018 | 322 | 0.120 |
Why?
|
| Humans | 14 | 2021 | 134143 | 0.120 |
Why?
|
| Transfection | 2 | 2016 | 1098 | 0.120 |
Why?
|
| Isoenzymes | 1 | 2015 | 231 | 0.120 |
Why?
|
| DNA, Complementary | 1 | 2016 | 472 | 0.120 |
Why?
|
| Genes, Reporter | 1 | 2016 | 399 | 0.110 |
Why?
|
| Body Weight | 1 | 2018 | 1041 | 0.110 |
Why?
|
| Computational Biology | 1 | 2019 | 890 | 0.110 |
Why?
|
| Promoter Regions, Genetic | 1 | 2018 | 1434 | 0.110 |
Why?
|
| Cell Line, Tumor | 2 | 2020 | 3799 | 0.110 |
Why?
|
| Epigenesis, Genetic | 1 | 2019 | 771 | 0.110 |
Why?
|
| Intestinal Mucosa | 1 | 2019 | 816 | 0.100 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2016 | 546 | 0.100 |
Why?
|
| Drug Therapy | 1 | 2012 | 94 | 0.100 |
Why?
|
| Neoplasms | 2 | 2020 | 3034 | 0.090 |
Why?
|
| Zoxazolamine | 1 | 2011 | 1 | 0.090 |
Why?
|
| Cytochrome P450 Family 2 | 1 | 2011 | 6 | 0.090 |
Why?
|
| Feces | 1 | 2015 | 789 | 0.090 |
Why?
|
| Arylsulfotransferase | 1 | 2011 | 6 | 0.090 |
Why?
|
| Steroid Hydroxylases | 1 | 2011 | 22 | 0.090 |
Why?
|
| Aryl Hydrocarbon Hydroxylases | 1 | 2011 | 44 | 0.090 |
Why?
|
| Metabolic Detoxication, Phase I | 1 | 2011 | 10 | 0.090 |
Why?
|
| Midazolam | 1 | 2011 | 46 | 0.090 |
Why?
|
| Metabolic Detoxication, Phase II | 1 | 2011 | 15 | 0.090 |
Why?
|
| Cyclin-Dependent Kinases | 2 | 2001 | 90 | 0.090 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2015 | 609 | 0.090 |
Why?
|
| Immunoblotting | 1 | 2011 | 319 | 0.090 |
Why?
|
| Communicable Diseases | 1 | 2012 | 164 | 0.080 |
Why?
|
| Thienamycins | 1 | 2009 | 14 | 0.080 |
Why?
|
| Interleukin-1beta | 1 | 2010 | 167 | 0.080 |
Why?
|
| Arthritis, Rheumatoid | 1 | 2012 | 296 | 0.080 |
Why?
|
| beta-Lactam Resistance | 1 | 2009 | 49 | 0.080 |
Why?
|
| Colorectal Neoplasms | 1 | 2015 | 652 | 0.080 |
Why?
|
| Macrophage Inflammatory Proteins | 1 | 2008 | 12 | 0.080 |
Why?
|
| NF-kappa B p50 Subunit | 1 | 2008 | 12 | 0.080 |
Why?
|
| Transcription Factors | 1 | 2019 | 2734 | 0.080 |
Why?
|
| Tissue Distribution | 2 | 2020 | 402 | 0.080 |
Why?
|
| MAP Kinase Kinase 4 | 1 | 2008 | 38 | 0.080 |
Why?
|
| Chemokines, CC | 1 | 2008 | 29 | 0.080 |
Why?
|
| Kupffer Cells | 1 | 2008 | 22 | 0.070 |
Why?
|
| NF-kappa B | 1 | 2011 | 483 | 0.070 |
Why?
|
| Selection, Genetic | 1 | 2009 | 169 | 0.070 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2011 | 1332 | 0.070 |
Why?
|
| Chemokines | 1 | 2008 | 138 | 0.070 |
Why?
|
| Sleep | 1 | 2011 | 370 | 0.070 |
Why?
|
| Pseudomonas aeruginosa | 1 | 2009 | 180 | 0.070 |
Why?
|
| Non-alcoholic Fatty Liver Disease | 1 | 2012 | 429 | 0.070 |
Why?
|
| Mutagenesis, Site-Directed | 2 | 2006 | 329 | 0.070 |
Why?
|
| Protein Kinases | 1 | 2008 | 345 | 0.070 |
Why?
|
| Serine | 2 | 2006 | 185 | 0.070 |
Why?
|
| Amino Acid Substitution | 2 | 2006 | 416 | 0.060 |
Why?
|
| Breast Neoplasms | 1 | 2019 | 2771 | 0.060 |
Why?
|
| Interleukin-1 | 1 | 2006 | 143 | 0.060 |
Why?
|
| Cyclin-Dependent Kinase 9 | 2 | 2001 | 31 | 0.060 |
Why?
|
| Binding Sites | 2 | 2006 | 1386 | 0.060 |
Why?
|
| Casein Kinase II | 1 | 2004 | 15 | 0.050 |
Why?
|
| Diabetes Mellitus | 1 | 2012 | 937 | 0.050 |
Why?
|
| RNA Polymerase III | 1 | 2004 | 43 | 0.050 |
Why?
|
| Oogenesis | 1 | 2004 | 57 | 0.050 |
Why?
|
| Mutation, Missense | 1 | 2007 | 948 | 0.050 |
Why?
|
| Mice, Knockout | 1 | 2011 | 4012 | 0.050 |
Why?
|
| Cyclin T | 1 | 2001 | 34 | 0.050 |
Why?
|
| Oocytes | 1 | 2004 | 302 | 0.050 |
Why?
|
| Positive Transcriptional Elongation Factor B | 1 | 2001 | 20 | 0.050 |
Why?
|
| Eukaryotic Initiation Factor-4E | 1 | 2021 | 55 | 0.040 |
Why?
|
| Immunophenotyping | 1 | 2001 | 344 | 0.040 |
Why?
|
| Esterases | 1 | 2020 | 13 | 0.040 |
Why?
|
| Recombinant Proteins | 1 | 2004 | 1436 | 0.040 |
Why?
|
| Bile | 1 | 2020 | 47 | 0.040 |
Why?
|
| Caco-2 Cells | 1 | 2020 | 97 | 0.040 |
Why?
|
| Phosphorylation | 1 | 2004 | 1713 | 0.040 |
Why?
|
| Cardiovascular Diseases | 1 | 2012 | 2091 | 0.040 |
Why?
|
| DNA Replication | 1 | 2001 | 359 | 0.040 |
Why?
|
| Immunization | 1 | 2021 | 315 | 0.040 |
Why?
|
| Lymphocyte Activation | 1 | 2001 | 695 | 0.040 |
Why?
|
| Female | 5 | 2020 | 72002 | 0.040 |
Why?
|
| Monocytes | 1 | 2001 | 357 | 0.040 |
Why?
|
| Mice, Inbred BALB C | 1 | 2021 | 1087 | 0.040 |
Why?
|
| Transcription, Genetic | 1 | 2004 | 1761 | 0.040 |
Why?
|
| Rats, Wistar | 1 | 2019 | 398 | 0.030 |
Why?
|
| Anti-Bacterial Agents | 1 | 2009 | 2587 | 0.030 |
Why?
|
| Middle Aged | 2 | 2019 | 29395 | 0.030 |
Why?
|
| Pharmacogenetics | 1 | 2017 | 203 | 0.030 |
Why?
|
| Stem Cell Transplantation | 1 | 2017 | 252 | 0.030 |
Why?
|
| Apoptosis | 1 | 2001 | 1945 | 0.030 |
Why?
|
| Aged | 1 | 2012 | 21789 | 0.030 |
Why?
|
| Rats | 1 | 2019 | 3876 | 0.020 |
Why?
|
| Colony Count, Microbial | 1 | 2009 | 89 | 0.020 |
Why?
|
| Pseudomonas Infections | 1 | 2009 | 122 | 0.020 |
Why?
|
| Adult | 2 | 2019 | 31943 | 0.020 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2006 | 132 | 0.020 |
Why?
|
| Survival Analysis | 1 | 2009 | 1595 | 0.010 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2006 | 805 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2019 | 13098 | 0.010 |
Why?
|
| Base Sequence | 1 | 2006 | 3180 | 0.010 |
Why?
|
| Lung | 1 | 2009 | 1577 | 0.010 |
Why?
|
| U937 Cells | 1 | 2001 | 25 | 0.010 |
Why?
|
| Receptors, Interleukin-2 | 1 | 2001 | 43 | 0.010 |
Why?
|
| Antigens, Differentiation, T-Lymphocyte | 1 | 2001 | 39 | 0.010 |
Why?
|
| HIV Long Terminal Repeat | 1 | 2001 | 20 | 0.010 |
Why?
|
| Gene Products, tat | 1 | 2001 | 28 | 0.010 |
Why?
|
| Tetradecanoylphorbol Acetate | 1 | 2001 | 68 | 0.010 |
Why?
|
| CD4 Antigens | 1 | 2001 | 57 | 0.010 |
Why?
|
| Jurkat Cells | 1 | 2001 | 94 | 0.010 |
Why?
|
| Lectins, C-Type | 1 | 2001 | 74 | 0.010 |
Why?
|
| Cell Line | 1 | 2006 | 2863 | 0.010 |
Why?
|
| Models, Biological | 1 | 2006 | 1538 | 0.010 |
Why?
|
| DNA | 1 | 2006 | 1684 | 0.010 |
Why?
|
| Transcriptional Activation | 1 | 2001 | 504 | 0.010 |
Why?
|
| Antigens, CD | 1 | 2001 | 448 | 0.010 |
Why?
|
| Child | 1 | 2017 | 25911 | 0.010 |
Why?
|